BACKGROUND Breast cancer risk estimates for atypical lesions are based primarily on case‐
control studies of patients with open biopsies. The authors report the cumulative breast …

Histopathologists are encountering intra‐lobular epithelial proliferations more frequently in
core biopsies taken from lesions identified in mammographic breast screening programmes …

Abstract Context.—Lobular neoplasias (LNs) of the breast include atypical lobular neoplasia
and lobular carcinoma in situ. Recent evidence suggests that LN is not only a risk factor for …

Background Lobular neoplasia (LN) represents a spectrum of atypical proliferative lesions,
including atypical lobular hyperplasia and lobular carcinoma-in-situ. The need for excision …

Atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS) are nonmalignant breast
lesions that confer a 4-to 10-fold increased risk for breast cancer in women. Often, AH and …

We have stratified the cancer risk implications of lobular pattern in situ neoplasias of the
breast by separating marked examples of this histologic spectrum (lobular carcinoma in situ …

Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) represent a
spectrum of breast disease referred to as" lobular neoplasia"(LN). Although LN occurs …

Context.—Both atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) have
traditionally been considered to be risk factors for the development of invasive carcinoma …

Background Using new molecular biology techniques, recent studies have implicated a
common evolutionary pathway between lobular neoplasia, lobular carcinomas, and …

The purpose of this study was to assess the accuracy of stereotactic vacuum‐assisted
biopsy (SVAB) for the diagnosis of high‐risk lesions, which include papillary lesions and …